Остеопороз и остеопатии (Apr 2011)

The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.

  • D Black,
  • I. R. Reid,
  • J. A. Cauley,
  • S Boonen,
  • F Cosman,
  • P C Leung,
  • P Lakatos,
  • Z Man,
  • S. R. Cummings,
  • T. F. Hue,
  • M. E. Ruzycky,
  • R Martinez,
  • G Su,
  • C Bucci-Rechtweg,
  • R Eastell

DOI
https://doi.org/10.14341/osteo2011137-37
Journal volume & issue
Vol. 14, no. 1
pp. 37 – 37

Abstract

Read online

No abstracts available.